S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Closing prices for crude oil, gold and other commodities
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
NASDAQ:RSTI

RofinSinar Technologies (RSTI) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$32.55
$32.55
50-Day Range
N/A
52-Week Range
$19.02
$32.55
Volume
N/A
Average Volume
209,055 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RSTI stock logo

About RofinSinar Technologies Stock (NASDAQ:RSTI)

ROFIN-SINAR Technologies Inc. is engaged in the design, development, engineering, manufacturing and marketing of laser sources and laser-based system solutions for industrial material processing applications, which include primarily cutting, welding and marking a range of materials. The Company offers a range of laser components. Its Laser macro products offering consists of laser products, which are produced and marketed under the brand names, including ROFIN, PRC, NELC, Nufern and DILAS. Its family of laser products for marking applications includes PowerLine, PowerLine Pico, MultiScan VS/HE and LabelMarker Series. Its laser micro product offering consists of laser products, which are marketed under the ROFIN, DILAS, Corelase and Lee Laser brand names.

RSTI Stock News Headlines

Technology
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Rofin-Sinar Stock Hits New 52-Week Low (RSTI)
See More Headlines
Receive RSTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RofinSinar Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Electronic Equipment & Instruments
Current Symbol
NASDAQ:RSTI
CUSIP
77504310
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

RSTI Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of RofinSinar Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RofinSinar Technologies investors own include General Electric (GE), II-VI (IIVI), Arrowhead Pharmaceuticals (ARWR), Array Technologies (ARRY), ArQule (ARQL), Aralez Pharmaceuticals (ARLZ), Ampco-Pittsburgh (AP), Amarin (AMRN), Alnylam Pharmaceuticals (ALNY) and First Majestic Silver (AG).

This page (NASDAQ:RSTI) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners